Vertex Pharmaceuticals Inc / Ma
VRTXNasdaqCIK 875320HealthcareFiscal year ends Dec 31
Reports and events: 289 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2010-10-2220:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-10-053291 |
| 2010-09-2920:43 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-10-050532 |
| 2010-09-2421:39 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-10-049716 |
| 2010-09-0720:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-10-047509 |
| 2010-08-1012:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-10-043367 |
| 2010-08-0320:41 ET | 10-Q | Quarterly reportPeriod 2010-06-30 | 0001047469-10-006916 |
| 2010-07-2820:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-10-040183 |
| 2010-07-1320:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-10-037843 |
| 2010-05-2520:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-10-030699 |
| 2010-05-1720:30 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-10-029095 |
| 2010-05-0320:33 ET | 10-Q | Quarterly reportPeriod 2010-03-31 | 0001047469-10-004633 |
| 2010-04-2120:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-10-021007 |
| 2010-04-1520:35 ET | DEF 14A | Proxy statementPeriod 2010-05-13 | 0001047469-10-003772 |
| 2010-02-1922:27 ET | 10-K | Annual reportPeriod 2009-12-31 | 0001047469-10-001033 |
| 2010-02-0421:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-10-004957 |
| 2010-01-1114:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-10-001021 |
| 2009-12-0421:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-09-068618 |
| 2009-11-1621:30 ET | 8-K | 3.02 Unregistered sale of equity | 0001104659-09-065256 |
| 2009-11-0921:45 ET | 10-Q | Quarterly reportPeriod 2009-09-30 | 0001047469-09-009834 |
| 2009-11-0313:46 ET | 8-K | 8.01 Other events | 0001104659-09-062024 |
| 2009-10-2620:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-09-060365 |
| 2009-10-0620:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-09-057968 |
| 2009-08-1020:21 ET | 10-Q | Quarterly reportPeriod 2009-06-30 | 0001047469-09-007495 |
| 2009-08-0520:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-09-047401 |
| 2009-08-0420:31 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-09-046933 |
| 2009-07-0920:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-09-042634 |
| 2009-06-1120:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001104659-09-037765 |
| 2009-05-1920:15 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-09-033604 |
| 2009-05-1120:31 ET | 10-Q | Quarterly reportPeriod 2009-03-31 | 0001047469-09-005373 |
| 2009-05-1120:30 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-09-031528 |
| 2009-04-1620:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-09-024599 |
| 2009-04-0812:05 ET | DEF 14A | Proxy statementPeriod 2009-05-14 | 0001047469-09-003942 |
| 2009-03-1322:49 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001047469-09-002579 |
| 2009-03-0920:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events | 0001104659-09-015534 |
| 2009-02-1921:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-09-010783 |
| 2009-02-1722:58 ET | 10-K | Annual reportPeriod 2008-12-31 | 0001047469-09-001305 |
| 2009-02-1021:06 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-09-007969 |
| 2009-02-0921:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-09-007673 |
| 2009-01-1514:26 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-09-002409 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 12:56 ET. Listed shows no prices and gives no investment advice.